Robert F. Kennedy Jr., President Donald Trump’s nominee for health secretary, reportedly expressed openness to seizing drug ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

Biden's FDA pushed a prohibition that disproportionately targeted marginalized communities. Trump's reversal may mark a shift ...

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

The global drug screening market is set to experience remarkable growth, expanding from USD 7.3 billion in 2023 to a ...

Shares of Leap Therapeutics slid after disappointing initial data from two mid-stage clinical trials of its oncology treatment, resulting in the discontinuation of one clinical program.

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

The comments mark the latest in a number of trade-related threats unleashed by Trump in recent days. Trump said he plans to ...

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...